We spotted a few investments in New England startups working on a mix of technology in life sciences and collaboration. Take a look. —Cambridge, MA-based Daktari Diagnostics, a maker of an HIV diagnostics system for use in developing countries, took in $1.17 million of a targeted $1.25 million debt round of funding, according to an … Continue reading “Funding for Diagnostics, Crowdsourced Problem Solving, & Medicine Counterfeiting Prevention”
Category: Boston
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO
Tony Coles was about nine years old when he decided to become a doctor. His father, a government accountant and a minister, told him that medicine and law were great professions. The younger Coles, a fan of math and science, opted for medicine. And even when teachers underestimated him, placing Coles in a math class … Continue reading “Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO”
Are Free Motorola Phones in Our Future? A VC’s Take on Why Google is Buying Motorola
I was invited to go on Bloomberg West TV on Monday when news broke of Google’s plan to acquire Motorola for $12.5 billion in cash. I hadn’t had much time to digest the news before going on live television and found myself verbalizing my gut instinct: that is, I think Google will at some point … Continue reading “Are Free Motorola Phones in Our Future? A VC’s Take on Why Google is Buying Motorola”
The Future of Life Sciences in New York: Xconomy to Convene its First Big NYC Event Oct. 13
I had only been at Xconomy a couple of weeks when I realized how hot the topic of biotech’s future in New York truly is. It was April, and I was one of the members of the press at the New York Biotechnology Association’s 20th annual meeting. The first panel I attended had a provocative … Continue reading “The Future of Life Sciences in New York: Xconomy to Convene its First Big NYC Event Oct. 13”
BuyWithMe CEO Jim Crowley Talks Strategy in Mobile, Payments, and Loyalty 2.0
There may be no such thing as loyalty anymore. But there is something called Loyalty 2.0—this is a new wave of companies helping stores and restaurants offer things like digital coupons, deals, and rewards to repeat customers. And a lot of Boston and New York startups are getting in on the trend. One of them … Continue reading “BuyWithMe CEO Jim Crowley Talks Strategy in Mobile, Payments, and Loyalty 2.0”
Tech Startup Investing, Following the Seasonal Pattern, Falls to $250M in July
Startups in the Bay State have taken a bit of a break from the feverish pace they were inking deals at earlier this summer. Last month, 34 startups pulled in $250.5 million in equity-based deals, down from the whopping $564.7 million they raised across 38 financings in June, according to data from Funding Flash, a … Continue reading “Tech Startup Investing, Following the Seasonal Pattern, Falls to $250M in July”
Finding Trends: Cleantech IPOs Skew Toward Biofuels, Materials, Energy Efficiency
Even before global markets reacted to the U.S. credit downgrade, IPOs for cleantech companies have been relatively few and far between. Still, the IPO data for the first half of 2011 reveals the kinds of alternative energy and green technology companies are going public—a good indication of which sectors are more likely to attract more … Continue reading “Finding Trends: Cleantech IPOs Skew Toward Biofuels, Materials, Energy Efficiency”
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News
This week’s New England deals list includes a mix of life sciences and IT companies. —Lexington, MA-based T2 Biosystems, a developer of a system for identifying biological substances such as proteins, small molecules, viruses, and DNA more cheaply and quickly than existing methods, took in $23 million in Series D financing. New T2 investor Aisling … Continue reading “Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News”
Computing in the Age of the $1000 Genome: Xconomy to Convene Next Big SF Event Oct. 24
An amazing innovation story has been unfolding the past few years in the field of gene sequencing, which is creating one of today’s biggest computing challenges. New DNA sequencing tools are improving at such a rapid pace that scientists say it will soon be possible to generate the 3-billion-letter signature of an individual’s DNA for … Continue reading “Computing in the Age of the $1000 Genome: Xconomy to Convene Next Big SF Event Oct. 24”
Innovate or Conserve Cash? The Growing Dilemma for Biotech Firms
There’s no doubt that managing a biotech company is an enduring challenge, even during less tumultuous economic times. Now, entrepreneurs are contending with resources that are incredibly tight, an economy that is unsettled, a stock market on a roller-coaster ride, and research and development budgets that are being slashed. The stewardship role entrusted to the … Continue reading “Innovate or Conserve Cash? The Growing Dilemma for Biotech Firms”
MobiFlex, With Rebranding, Tries to Change How Businesses Make Mobile Apps (No Coding)
You can tell a sub-industry has really taken off when you see startups appearing out of nowhere to go after it. I’m talking about mobile apps for businesses. And Wellesley, MA-based MobiFlex, while not quite coming out of nowhere, has emerged on the scene with an interesting approach. The startup, not quite a year old, … Continue reading “MobiFlex, With Rebranding, Tries to Change How Businesses Make Mobile Apps (No Coding)”
Zerto Secures $15,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=20c86303-b7d6-4889-a87a-ea3a649728cd&Preview=1 Date 8/16/2011 Company Name Zerto Mailing Address 930 Winter Street Waltham, MA 02451 Company Description Zerto is the industry’s first hypervisor-based, virtual-aware, replication solution for tier-one applications. It closes a critical gap in cloud and enterprise business continuity and disaster recovery (BC/DR). Website http://www.zerto.com Transaction Type Venture Equity Transaction Amount $15,000,000 … Continue reading “Zerto Secures $15,000,000 Series B Round”
PeerTransfer Nabs $7.5M for Tuition Payment Processing Tech
Boston-based PeerTransfer, a developer of technology for more cheaply and efficiently processing college tuition payments from international students, has inked a deal itself. The startup announced today that it has completed a $7.5 million Series A financing, led by Spark Capital, and which included Accel Partners, Maveron, and Boston Seed Capital. The new cash will … Continue reading “PeerTransfer Nabs $7.5M for Tuition Payment Processing Tech”
Evergreen Solar Seeks Bankruptcy Protection, Slices Another 65 Jobs, Suspends MI Plant
The Evergreen Solar story keeps getting worse. The Marlboro, MA-based solar technology company revealed today that it is filing for Chapter 11 bankruptcy protection in U.S. Bankruptcy Court in Delaware. The court documents were not available online today, but other media outlets have reported that Evergreen (NASDAQ: [[ticker:ESLR]]), with assets of $424.5 million, owed its roughly … Continue reading “Evergreen Solar Seeks Bankruptcy Protection, Slices Another 65 Jobs, Suspends MI Plant”
Startups: Always Have a Plan B
One of the key distinctions between an entrepreneur and an operating executive is an entrepreneur’s almost seamless agility in the face of changing circumstances versus an operating executive’s intense execution focus on a plan. World-class entrepreneurs learn how to combine both. WTF? Driving home over the mountains from a Coastal Commission hearing, I had time … Continue reading “Startups: Always Have a Plan B”
Embera Takes In $4.5M
Embera NeuroTherapeutics, a Sudbury, MA- and Shreveport, LA-based developer of drugs for treating addictions, has added another $4.5 million in Series A financing, the company announced today. The money comes from Embera’s existing backers, Louisiana Ventures, Louisiana Fund I, and Themelios Ventures, as well as other private investors. The funding will go to supporting the … Continue reading “Embera Takes In $4.5M”
Boston’s E-Mail Apps Mini-Cluster Is Looking To Help Users Sell, Serve, Organize, and Even Play More Efficiently
The West Coast might have all the big names in e-mail platforms, but Boston’s doing plenty when it comes to building technology on top of those existing foundations. There are a number of established players that have been around and working on technology for things like managing e-mail outboxes (SMTP), bulk mailings (Constant Contact), and … Continue reading “Boston’s E-Mail Apps Mini-Cluster Is Looking To Help Users Sell, Serve, Organize, and Even Play More Efficiently”
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments
Pulmatrix, the Lexington, MA-based company with an unusual strategy for fighting diseases of the lungs, is announcing today that it has secured $14 million in a Series B1 venture round, bringing the total amount raised by the company to $60 million. All of Pulmatrix’s existing investors participated, including Polaris Venture Partners, 5AM Ventures, Arch Venture … Continue reading “Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments”
Time to Cure Cancer or Stash Cash Under the Mattress?
If you dared to flip the channel to CNBC any time during the past week, it would have been hard to stay calm. The market was whipsawing all over the place, up one minute, down the next. Fear of government defaults and the potential for another recession were topics of endless debate. Fund managers were … Continue reading “Time to Cure Cancer or Stash Cash Under the Mattress?”
Pulmatrix Secures $14,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cdde41b5-0245-4c47-85f4-5286a17ef4da&Preview=1 Date 8/15/2011 Company Name Pulmatrix Mailing Address 99 Hayden Avenue Lexington, MA 02421 Company Description Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. Website http://www.pulmatrix.com Transaction Type Venture Equity Transaction Amount $14,000,000 Transaction Round Series B Proceeds … Continue reading “Pulmatrix Secures $14,000,000 Series B Funding”
TransMedics Garners $5,922,498 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ae92066d-31b5-4028-bc42-917c3dd48b4f&Preview=1 Date 8/15/2011 Company Name TransMedics Mailing Address 200 Minuteman Road Andover, MA 01810 Company Description TransMedics has developed a revolutionary new system that enables living organ transplants. Website http://www.TransMedics.com Transaction Type Venture Equity Transaction Amount $5,922,498 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms … Continue reading “TransMedics Garners $5,922,498 New Financing”
peerTransfer Receives $7,500,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=213009c4-b44b-49fd-9786-42e8cde6472a&Preview=1 Date 8/15/2011 Company Name peerTransfer Mailing Address One Cambridge Center Cambridge, MA 02142 Company Description peerTransfer is the pioneer in low cost online international money transfer and global payments, helping individuals and businesses securely transfer funds internationally while saving money. Website http://www.peerTransfer.com Transaction Type Venture Equity Transaction Amount $7,500,000 Transaction Round … Continue reading “peerTransfer Receives $7,500,000 Series A Financing”
Another $15.2M for Proteon
Waltham, MA-based Proteon Therapeutics, a developer of drugs for kidney and vascular disease, has brought in another $15.2 million in equity- and options-based funding from 19 investors, an SEC filing shows. The biotech company’s last financing was in 2009, when it announced raising $12 million from new backers Bessemer Venture Partners and Devon Park Bioventures to bring … Continue reading “Another $15.2M for Proteon”
Fluidnet Finds $25M
[Updated on 8/23/11 at 10:10 am.] Amesbury, MA-based Fluidnet, which makes electronic infusion pumps for administering IV fluids, announced it has closed a $25 million Series C financing. The deal was led by new investor Fidelity BioSciences and included new investor SCP Vitalife Partners as well as previous backers Cardinal Partners, Easterly Capital and Rockport Venture Partners. The … Continue reading “Fluidnet Finds $25M”
There Is an Incubator Bubble—And It Will Pop
This week we published the third annual edition of the Xconomy Guide to Venture Incubators. It’s the only source we know of where U.S. entrepreneurs starting technology, life sciences, or energy companies can survey all of the early-stage mentoring and investment programs open to them in a single document. (You can buy the downloadable file … Continue reading “There Is an Incubator Bubble—And It Will Pop”
Zen and the Art of Motorcycle Monsoon Maintenance: Roof For Two Goes After Indian Market
If you see a couple of guys riding around on a motorcycle with a weird contraption over their heads, don’t worry, it’s not the latest fraternity hazing ritual. You might have caught a glimpse of a local startup testing out what could be a very global product. Especially if it’s raining. Boston-based Roof For Two … Continue reading “Zen and the Art of Motorcycle Monsoon Maintenance: Roof For Two Goes After Indian Market”
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News
It seems that IT news has dominated this week, so we’re bringing you a short and sweet roundup of life sciences funding and drug development news from around New England. —Cambridge, MA-based Ironwood Pharmaceuticals (NASDAQ: [[ticker:IRWD]]) and New York-based Forest Laboratories (NYSE: [[ticker:FRX]]) announced that they submitted a new drug application to the FDA for … Continue reading “T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News”
Proteon Therapeutics Garners $15,183,371 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c5db6c2-71b6-4919-930e-2cd613866a3a&Preview=1 Date 8/12/2011 Company Name Proteon Therapeutics Mailing Address 200 West Street Waltham, MA 02451 Company Description Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. Website http://www.proteontherapeutics.com Transaction Type Venture Equity … Continue reading “Proteon Therapeutics Garners $15,183,371 New Financing Round”
Aciex Obtains $8,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=44ae8a93-850c-4ab2-bca3-d4bf612b3c09&Preview=1 Date 8/12/2011 Company Name Aciex Mailing Address 863 Turnpike Avenue North Andover, MA 01845 Company Description The company develops unspecified therapeutic products. Website Undisclosed Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture Investor Undisclosed
Fluidnet Receives $19,825,040 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6846a56-20a5-4392-8bef-f17bb9b0b110&Preview=1 Date 8/12/2011 Company Name Fluidnet Mailing Address 21 Water Street 5th Floor Amesbury, MA 01913 Company Description The company sells a low-cost, simple, highly portable and capable IV infusion pump. Website http://www.fluidnet.net Transaction Type Venture Equity Transaction Amount $19,825,040 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory … Continue reading “Fluidnet Receives $19,825,040 New Financing”
Start Smart: An 8 week hands-on workshop for startups
For eight Mondays, entrepreneurs can check out these workshops, focused on the different phases of getting a startup launched. Speakers from a range of New England tech and venture firms will discuss stages like building your team, raising capital, and creating marketing and sales plans. More information and registration is here.
BioPharm America 2011
BioPharm America is designed to bring biotech and pharma executives to help them form strategic partnerships. Featured speakers come from Celgene, Abbott, Pfizer, Shire, Atlas Venture, and PureTech Ventures. Register before September 2 to avoid the onsite registration fee.
American Superconductor Cuts Staff, Scrambles to Get Finances on Track
It has been a rough spring and summer for American Superconductor. The Devens, MA-based energy tech company (NASDAQ: [[ticker:AMSC]]) said today it has cut 30 percent of its workforce, about 150 positions, since March 31 and expects to employ nearly 600 people worldwide after the cuts. The firm also said it expects to submit a … Continue reading “American Superconductor Cuts Staff, Scrambles to Get Finances on Track”
Innovation Series Event: From Social Insights to Social Business
This event aims to take a look at the ways social is affecting how businesses connect with customers and how they go about processes like market research and product development. Speakers come from firms such as Ford Motor Company and Sapient Nitro. Check here for registration and full event details.
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund
Here in Boston, we like to tout our universities, our faculty, our students. The academic community is one of the crowning strengths of the New England economy, not to mention a major driver of its global impact. But what have universities done for the local startup and business innovation community lately? I’m not going to … Continue reading “Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund”
HubSpot Board Swaps In Simon for Goodman, Levin Joins MTDC, & More Tech Personnel Moves
Lots of comings and goings in the Boston technology scene in the past week. Here’s a sampling of notable high-level moves: —Michael Simon, founder and CEO of LogMeIn (NASDAQ: [[ticker:LOGM]]), has joined the board of Cambridge, MA-based HubSpot, the marketing tech company. Simon replaces former (and longtime) HubSpot board member Gail Goodman, the CEO of … Continue reading “HubSpot Board Swaps In Simon for Goodman, Levin Joins MTDC, & More Tech Personnel Moves”
Affirmed Networks Lands $1,400,002 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=df845ac7-baad-498c-a111-05e420082cc1&Preview=1 Date 8/11/2011 Company Name Affirmed Networks Mailing Address 35 Nagog Park Second Floor Acton, MA 01720 Company Description Affirmed Networks is an exciting new company located in the Boston area developing new technologies for the wireless industry. Website http://www.affirmednetworks.com Transaction Type Venture Equity Transaction Amount $1,400,002 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Affirmed Networks Lands $1,400,002 New Funding Round”
SemiNex Garners $639,773 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c56d421e-109e-402e-9742-3f43bc23d9c6&Preview=1 Date 8/11/2011 Company Name SemiNex Mailing Address 100 Corporate Place Peabody, MA 01960 Company Description SemiNex aims to fundamentally transform key industries by displacing conventional laser technology with super-high-power semiconductor diode lasers, enabling new cost-effective laser applications. SemiNex provides better performance and laser efficiency while drastically reducing the laser size and … Continue reading “SemiNex Garners $639,773 New Round”
FutureM: The Future of Marketing
FutureM is a series of events throughout Boston and Cambridge that focuses on cutting-edge marketing technologies. Programs cover subjects such as sports marketing, marketing design, customer experience, digital media, mobile marketing, and much more. Register here to get the pass to the events.
Vlingo Cleared in 1st Patent Infringement Case
A federal jury in Boston found Cambridge, MA-based Vlingo’s speech recognition software did not infringe on a patent owned by Nuance Communications (NASDAQ: [[ticker:NUAN]]), the companies said in two separate announcements (here and here). Burlington, MA-based Nuance has alleged that Vlingo has infringed on a number of its patents, but this particular patent, 6,766,295, covers the technique … Continue reading “Vlingo Cleared in 1st Patent Infringement Case”
Carbonite Expected to Go Through With Smaller IPO; Venture Investors See Upside
[Updated 8/10/11 5:50 pm. See below.] What’s happening with Carbonite’s IPO? The Boston-based online data backup firm is dealing with an extremely volatile stock market this week—as are a bunch of other U.S. companies trying to go public. But it’s looking like Carbonite’s initial public offering could go through tomorrow at a much reduced price, with … Continue reading “Carbonite Expected to Go Through With Smaller IPO; Venture Investors See Upside”
Xconomy Guide to Venture Incubators Back For A Third Year, Sixty-Four Programs Strong
You could say that the institution of the startup incubator has gotten its chance to shine this year. One way we can tell? Our third annual Xconomy Guide to Venture Incubators has nearly doubled in size from the 2010 version. The big boom wasn’t a total surprise, given that this year politicians and the like … Continue reading “Xconomy Guide to Venture Incubators Back For A Third Year, Sixty-Four Programs Strong”
T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools
Some interesting funding news in the biotech world today. Lexington, MA-based T2 Biosystems, a diagnostics technology firm, says it has closed a $23 million Series D financing round led by new investor Aisling Capital. The round also included previous investors Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners, Physic Ventures, Partners Healthcare, Arcus Ventures, RA … Continue reading “T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools”
Helmsley Trust Funds New Boston-Based Website for Diabetes Patients
In New York, the name Leona Helmsley often evokes snarky jokes about Trouble, the pooch who inherited $12 million in 2007, when the hotel heiress known as the Queen of Mean died. So it might be a surprise to many New Yorkers to learn that Helmsley and her husband, Harry, set up a charitable trust … Continue reading “Helmsley Trust Funds New Boston-Based Website for Diabetes Patients”
Avalon Leads $3M Nanigans Deal, M/A-COM Seeks IPO, Bluesocket Bought by ADTRAN, & More Boston-Area Deals News
IT companies dominated New England deals this week, with word of acquisitions, financings, and potential IPOs. —M/A-COM Technology Solutions, a Lowell, MA-based wireless chip maker, said in an SEC filing that it hopes to raise up to $230 million in an initial public offering. The firm is now owned by semiconductor-focused private equity fund Gaas … Continue reading “Avalon Leads $3M Nanigans Deal, M/A-COM Seeks IPO, Bluesocket Bought by ADTRAN, & More Boston-Area Deals News”
Copiun Obtains $1,638,717 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5af96de8-e3c9-42e3-aed5-35d40de5bb1a&Preview=1 Date 8/10/2011 Company Name Copiun Mailing Address 313 Boston Post Rd. W. Marlborough, MA 01752 Company Description Copiun has set out to provide a solution for User Data Management that is less rather than more – less for end users to do, less for IT administrators to do, and less expensive. … Continue reading “Copiun Obtains $1,638,717 New Funding Round”
High Street Partners Lands $6,300,000 Series C Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f1109eb3-2bb0-4141-866d-4e1b32db3c2a&Preview=1 Date 8/10/2011 Company Name High Street Partners Mailing Address 31 St. James Ave. Boston, MA 02116 Company Description High Street Partners (HSP) is the leader in international business services, providing a single source for the implementation and ongoing management of international subsidiaries and other entities, including registration, payroll, accounting, bookkeeping, tax … Continue reading “High Street Partners Lands $6,300,000 Series C Financing Round”
T2 Biosystems Receives $23,000,000 Series D Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=409de479-0369-47c1-908f-d3d3f1a46831&Preview=1 Date 8/10/2011 Company Name T2 Biosystems Mailing Address 101 Hartwell Avenue Lexington, MA 02421 Company Description T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at … Continue reading “T2 Biosystems Receives $23,000,000 Series D Financing Round”
Ironwood, Forest Seek FDA Approval
Cambridge, MA-based Ironwood Pharmaceuticals (NASDAQ: [[ticker:IRWD]]) and New York-based Forest Laboratories (NYSE: [[ticker:FRX]]) announced today that they have submitted an application to the FDA for approval of their drug linaclotide, a treatment for irritable bowel syndrome with constipation and chronic constipation.The application includes safety and efficacy data from two long-term safety studies and four placebo-controlled clinical … Continue reading “Ironwood, Forest Seek FDA Approval”
Nanigans Inks $3M Series A
[Corrected 8/10/11, 2:25 pm. See below.] Nanigans, a Boston-based provider of a real-time bidding advertising platform for Facebook, announced today that it has closed a $3 million Series A round, led by Avalon Ventures. Nanigans said that it will be adding Avalon’s Rich Levandov to the board as a result of the funding, which also came … Continue reading “Nanigans Inks $3M Series A”